---
figid: PMC11347096__nihms-2007498-f0005
figtitle: Schematic diagram summarizes the regulation of lipid metabolism in normal
  or malignant B cells
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11347096
filename: PMC11347096__nihms-2007498-f0005.jpg
figlink: /pmc/articles/PMC11347096/figure/F5
number: F5
caption: The schematic diagram summarizes the regulation of lipid metabolism in normal
  or malignant B cells. In response to foreign antigens, BCR signaling triggers a
  pro-inflammatory immune response via activation of the NF-κB signaling pathway and
  promotes intensive proliferation supported by various lipid species such as fatty
  acids, PG, CL, sphingolipids, phospholipids, and cholesterol. In B cell malignancy,
  constitutive BCR signaling, achieved by mutations in genes such as BCR-ABL1 in early
  B cell leukemia or PI3K, MYC, PTEN, CD79B, CARD11, MYD88, and RAS in mature B cell
  lymphoma, contributes to uncontrolled cell proliferation, survival, and drug resistance
papertitle: Leveraging altered lipid metabolism in treating B cell malignancies
reftext: Jaewoong Lee, et al. Prog Lipid Res. 2024 Jul 17;95(NA).
year: '2024'
doi: 10.1016/j.plipres.2024.101288
journal_title: Progress in lipid research
journal_nlm_ta: Prog Lipid Res
publisher_name: .na.character
keywords: Lipid metabolism | B cell malignancy | Leukemia | Lymphoma | B cell receptor
  | Obese
automl_pathway: 0.9027377
figid_alias: PMC11347096__F5
figtype: Figure
redirect_from: /figures/PMC11347096__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11347096__nihms-2007498-f0005.html
  '@type': Dataset
  description: The schematic diagram summarizes the regulation of lipid metabolism
    in normal or malignant B cells. In response to foreign antigens, BCR signaling
    triggers a pro-inflammatory immune response via activation of the NF-κB signaling
    pathway and promotes intensive proliferation supported by various lipid species
    such as fatty acids, PG, CL, sphingolipids, phospholipids, and cholesterol. In
    B cell malignancy, constitutive BCR signaling, achieved by mutations in genes
    such as BCR-ABL1 in early B cell leukemia or PI3K, MYC, PTEN, CD79B, CARD11, MYD88,
    and RAS in mature B cell lymphoma, contributes to uncontrolled cell proliferation,
    survival, and drug resistance
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BTK
  - BCR
  - RN7SL263P
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - CD79A
  - MBTPS1
  - HSD11B1
  - ALB
  - APOA1
  - APOA2
  - APOE
  - CLU
  - KRAS
  - HRAS
  - NRAS
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - ABL1
  - SPHK1
  - SPHK2
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - NFKB1
  - UGCG
  - ATP8A2
  - MYC
  - PTEN
  - PTPA
  - FASN
  - SRC
  - FGR
  - FYN
  - YES1
  - CARD11
  - MYD88
  - S1P
  - RAS
  - Ceramide
  - Glucosylceramide
  - ATP
  - Fatty acid
---
